Nalin Tikoo, M.S.

TrapezoidX, Inc.

Nalin is the President & CEO of TrapezoidX. With TrapezoidX, Nalin continues on with his mission to enable data-driven decisions in clinical drug development, partnering specifically with biotech and pharma startups to address their clinical data analytics needs.

Prior to TrapezoidX, Nalin was the Sr. Director of Analytical Programming at Alector and has held positions with increasing responsibilities at BioMarin, Genentech, and Roche Diagnostics over a period of over 20 years.

As a seasoned Drug Development and Diagnostics Clinical Data Science leader, Nalin possesses extensive expertise in Programming and Clinical Data Analytics Systems. He has a proven track record of defining organizational structure, direction, business operations, and people development while maintaining strong hands-on programming skills and staying abreast of industry best practices.

A dedicated lifelong learner, Nalin continuously enhances his skills, such as R programming and effective graphical techniques, to maximize his team's value to the organization. Passionate about leveraging new and improved technology applications in Clinical Data Science, he evaluates and implements best-practice solutions to address organizational business needs.

Nalin is a self-motivated individual who has actively contributed to the Bay Area Data Science community through the Bay Area BioPharma Statistics Workshop (BBSW) since 2021 and was a member of the team responsible for introducing the Data Science & Programming Track at this annual conference in 2023.